Cargando…
Rituximab: mechanisms and applications
Autores principales: | Johnson, P W M, Glennie, M J |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2001
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2363990/ https://www.ncbi.nlm.nih.gov/pubmed/11742477 http://dx.doi.org/10.1054/bjoc.2001.2127 |
Ejemplares similares
-
Analysis of the interaction of monoclonal antibodies with surface IgM on neoplastic B-cells
por: Cragg, M S, et al.
Publicado: (1999) -
Internalization of Rituximab and the Efficiency of B Cell Depletion in Rheumatoid Arthritis and Systemic Lupus Erythematosus
por: Reddy, Venkat, et al.
Publicado: (2015) -
Demonstration of highly specific toxicity of the α-emitting radioimmunoconjugate(211)At-rituximab against non-Hodgkin's lymphoma cells
por: Aurlien, E, et al.
Publicado: (2000) -
Obinutuzumab induces superior B-cell cytotoxicity to rituximab in rheumatoid arthritis and systemic lupus erythematosus patient samples
por: Reddy, Venkat, et al.
Publicado: (2017) -
Novel applications of Rituximab in dermatological disorders
por: Bhandari, Prasan R., et al.
Publicado: (2014)